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INTRODUCTION 
Electro Convulsive Therapy (ECT) is a technique involving the 
application of electric current with the help of electrodes that are placed in the 
cranial vault under anesthesia. Convulsions are induced by delivering electrical 
charges through the electrodes. It has been used as a therapeutic procedure for 
the treatment of psychiatric illness for past sixty years. ECT is reported to be 
beneficial for pharmacological resistant mental illnesses1. ECT has shown very 
good results in patients with catatonia, major depressive disorder, 
schizophrenia and mania. It is used when there is poor drug compliance or in 
emergency situations such as aggression, suicidality, poor intake etc,. Many 
physiological changes occur after ECT, one of which is diminished cognition. 
Effects of ECT on cognition are an area of intense debate. Some researchers 
claim that there will be diminished cognition particularly memory impairment 
after ECT while others are of the view that it will improve since mental illness 
declines after ECT. Effects of ECT on cognition depend upon several factors 
like frequency of treatment, previous cognitive functions, technique with which 
ECT is administered, dose of anesthetic medications. Literature and studies 
reports of disagreement on the relative importance of these major issues1,2. 
Effects on cognitive functions seems to be a major barrier for ECT 
administration and its negative views although many research are of view that 
these effects are mild and short lived. Wave forms, electrode placement, 
intensity of stimulus and pulse width are some factors which play a significant 
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role on cognition after ECT. The current study aims to estimate the cognitive 
functions in patients before and after ECT. 
 ECT has been constantly under criticism in both professional and public 
views because of the presumed ideas about the effects of ECT on cognitive 
functions. Most of the studies are of the opinion that these effects are mild and 
short lived but the opposite view regarding these effects plays a major barrier 
in the broad application of ECT practice. The wave forms in which stimulus is 
given, intensity of stimulus applied and pulse width are all known to have an 
impact on the cognitive functions. ECT given in brief pulse wave form has less 
such morbidity. A variety of technical factors like the type of electrode 
placement and many such factors has an impact on cognitive functions1,2. Even 
the exact mechanism of action of ECT is still inconclusive and many theories 
have been postulated regarding the mechanism of action.   
The current study aims to assess the short term effect of ECT on 
cognitive functions in patients subjected to ECT. This study also compares the 
cognitive functions before and after administration of ECT. 
RATIONALE OF THE STUDY 
  There is need to study the cognitive effects of ECT, because ECT 
is usually given as per protocol in a clinical setting. The pattern, method of 
placement and also intensity of stimulus influences the cognitive outcomes in 
the post ECT period. The study of the type and also the extent of cognitive 
functions before and after ECT administration will help us to evaluate the 
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setting at which it should be clinically given and also help us to explore the 
mechanism of its action still further. Finally it helps us in planning for future 
treatments taking the cognitive functions into account and to properly assess 
the risk benefit ratio before administration of ECT.   
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REVIEW OF LITERATURE 
 In 16th century Swiss alchemist Paracelsus found to cure lunacy by 
inducing convulsions with the help of camphor. Later in the 18th and 19th 
century, cases were reported in which convulsions were induced by the use of 
camphor in oil. Some physicians observed that mental illness decreased after 
seizure episode in patients with both disorders.3 Ladislaw Meduna, a 
Hungarian psychiatrist, in 1934 found an inverse relationship between seizures 
and schizophrenia. He used camphor induced seizures to treat catatonic 
schizophrenia.4 Camphor was soon replaced with pentylenetetrazol as camphor 
was causing toxic side effects. But pentylenetetrazol caused unpleasant 
experience to patients5. To overcome this, Italian psychiatrists Ugo Cerletti 
and Lucio Bini came up with the technique inducing seizures by electrical 
method. In 1938, they treated an unknown 39-year old man who was suffering 
from catatonic schizophrenia by electrical methods. After 11 cycles of 
treatments, he recovered. This lead to the development of ECT as a treatment 
for various mental disorders.5 But were concerns about the safety of patients 
because of the side effects which includes fractures and cognitive impairment. 
Curare, a muscle relaxant was developed by A.E. Bennett in 1940. With the 
later developments of better apparatus and anesthetic agents the usage of ECT 
has seen a remarkable growth.  
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The National Institute for Health and Care Excellence (NICE) recommends 
the use of ECT for the following cases: 
 For treating severe depression 
 For treating catatonia 
 For treating severe mania 
ECT should be used as a last resort when other treatment options have 
failed or in the case of life threatening issues. The decision to apply ECT 
should involve carefully weighing the benefits and analyzing the risks for the 
patient. The major risks that should be considered are the usage of anesthesia 
and in case of other illnesses. Care should be taken when it is applied for 
pregnant women and elderly people as the risk involved is higher.6 
Nowadays ECT is prescribed for patients having major depressive disorder 
with suicidal tendencies, depression with psychosis, catatonia, mania, 
schizophrenia, post-traumatic stress disorder, Parkinson’s disease, delirium, 
tardive dyskinesia, neuroleptic malignant syndrome, intractable seizure 
disorder and obsessive compulsive disorder.7 
 
MECHANISM OF ACTION (MOA) 
 Though ECT has been in existence for more than 70 years, the 
mechanism of action is inconclusive. Several theories have been postulated 
regarding its mechanism. Some of which are discussed below 
6 
 
 Psychological theories 
Psychological theories include Psychoanalytic and Non-Psychoanalytic 
theories. According to the psychoanalytic theories the mechanism involves 
regression, fear and punishment theories. These theories became obsolete 
when muscle relaxant and anesthesia came into use for ECT as studied by 
Miller E, 1967.8 
According to the non-psychoanalytic theories the mechanism involves brain 
damage and amnesia. Summerskill et al., 19529 suggested that brain 
damage theory was framed due to the similarities observed between the 
Rorschach’s test results of patients after ECT and diffuses brain damage. 
However no change in the structure of brain was found post-ECT in 2-3 days 
in the study by Coffey et al., 198910. Also no MRI changes were found for a 
period of 1 week as reported by Pande et al., 199011. According to 
Devanand et al., 199512 human autopsy results showed no structural brain 
damage. Amnesia of pre-treatment experiences was common in post-ECT 
patients. Amnesia theory was nullified due to the lack of relation between 
therapeutic efficacy and amnesia in latest techniques of unilateral ECT as 
reported by Lawson et al., 199013. 
 Neurophysiological theories  
The MOA of ECT can be explained by theories dealing with the 
physiological changes caused by it, which are Sleep, Anticonvulsant and 
Neurogenesis theory. 
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EEG changes such as frequency reduction and increased amplitude of 
delta waves were noted after ECT. This is similar to that of normal sleep 
pattern. Charlton, 199914 reported that the seizure caused by ECT induces 
natural and deep restorative sleep. But Weiner et al., 198415 suggested that 
the relation of therapeutic response with EEG slowing is inconsistent. 
Certain studies also suggest sleep deprivation as a good antidepressant. 
Eriksson et al., 199816 and Gloud et al., 199817 reported that the 
Hippocampus is where neurogenesis occurs in humans. Studies by Shah et 
al., 199818 and Sheline et al., 199919 have shown decreased hippocampal 
volume after major depression. Depression also causes degeneration and 
decreased proliferation. ECT might reverse this by stimulation of neuronal 
proliferation. 
Anticonvulsant theories are formulated using the results from 
ECT/Seizure disorders. Threshold for seizures increases after ECT as 
reported by Kalinowsky & Kennedy, 194320 which is attributed to 
alteration in opioid and GABA transmission by Issac et al., 1986.21 
GABAergic transmissions is increased post-ECT which in turn contributes 
to the threshold increase. Another conclusion is that ECS releases opioid 
like endogenous anticonvulsant substance by Holaday et al., 1986.22 There 
was decrease in the duration of seizure after ECT by Sackeim et al., 1986 
& 1987c.23,24 This reduction has no association with the therapeutic 
response of ECT. Inhibitory process begins during the ictus and manifests 
to the immediate postictal period. Superior therapeutic effects have been 
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observed when there is high amplitude slow wave in the delta activity by 
Nobler et al., 1993.25The inhibitory process is linked with efficacy thus 
supporting the anticonvulsant theory. The Cerebral Blood Flow (CBF) and 
Cerebral Metabolic Rate (CMR) are reduced in anterior frontal regions and 
in immediate postictal period which gives very good clinical outcome by 
Volkow et al., 1988.26The study by Bonne et al., in 199627 opposes this 
fact. There is a relation between seizure threshold and CBF which supports 
the anticonvulsant theory. There is a substantial increase of slow waves in 
the inter-ictal period after application of ECT by Sackeim et al., 1996.28 
Various findings show that the reduction in the functional activity of a 
particular brain region might be the reason for the therapeutic response of 
ECT by Abrams et al., 1992.29 The EEG coherence of anterior inter-
hemispheres was found to be decreased in patients with depression which 
was responsible for better response of ECT. The link between such changes 
and the reduced response to ECT and medication was studied by Leuchter 
et al., 1997.30This fact gives a direct association of anticonvulsant and 
antidepressant.  
Neurochemical theories 
 Serotonin (5HT) 
The levels of 5HT are not affected by ECT, but serotonin is found to be 
released as a response to therapy while using antidepressants. The 
variations in levels of 5HT1a and 5HT2a are shown below:  
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Receptors ECT Antidepressant drugs 
5HT1a  No response Decreases 
5HT2a Increases Decreases 
  
So the results are similar for ECT but are in opposition with that of 
antidepressant drugs. 
 Norepinephrine (NE) 
Norepinephrine levels were not altered by Slade 1980.31 In beta receptor 
varying results have been found, beta receptors increased responsiveness on 
lymphocyte after ECT by Mann et al., 1990.32 Post synaptic beta receptor 
down regulation and no change after ECT in some studies done by Cooper 
et al., 1985.33 
Human studies revealed number of alpha-2 platelet receptor was 
decreased after ECT by Smith et al., 1983.34 
Alpha 1 receptor number is increased in hippocampus after ECT was 
reported by Vetulani et al., 1983.35 
 
 Dopamine 
Dopamine in striatum and dopamine receptors increases after ECT.  
Functional polymorphism occurs in dopamine D2 receptor. This receptor is 
responsible for the regulation of postsynaptic effects and COMT gene 
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which in turn metabolizes dopamine and noradrenaline. This is linked with 
varying response to ECT. 
 GABA(Gamma-aminobutyric acid) 
On comparing the GABA levels of ECT responders with non-
responders, it was found that the mean level of GABA was higher for ECT 
responders by Devanand et al., 1995.36The other factors that should be 
considered are the increase in glutamic acid decarboxylase, enhanced 
GABAergic function, augmentation of GABA receptor and increase in the 
Thyrotropin-Releasing Harmone (TRH).  
 Glutamate 
Long term ECT is found to cause an increase in Glutamate receptor 
expression and this might contribute to the better induction of brain derived 
neurotrophic factor (BDNF) by Naylor et al., 1996.37The adverse effects of 
ECT may be accounted to the activation of glutamate receptors 
(hippocampus) during the seizure. 
 Melatonin 
The day night ratios of melatonin levels were higher in Pre-ECT patients 
when compared with Post-ECT patients by Krahn et al., 2000.38Thus 
the findings are inconclusive. 
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 Endocrine effects 
ECT produces Diencephalic stimulation as a result of which 
neuropeptide dysregulation is corrected by Abrams & Taylor., 1976.39 
ECT also increases blood drain barrier permeability which increases 
neuropeptide distribution through CNS. Prolactin release is higher in 
bilateral ECT when compared with unilateral ECT. Also it is higher in high 
dose stimulation when compared with low dose stimulation by Deakin et 
al., 1983.40There is a direct correlation between prolactin surge induced by 
ECT and the clinical improvement in depression Lisanby et al., 1998.41  
 Neuropeptides 
After the application of ECT, there is a considerable increase in the 
values of Neuropeptide Y (NPY), endothelin and somatostatin by Mathe et 
al., 1999.42The maximum amount of variation is seen in the hippocampus. 
 Intracellular mechanisms 
BDNF expression was regulated by ECT which is seen in dentate gyrus 
of hippocampus by Lindefors et al., 1995.43 It is mediated by glutamate 
receptor activation and its expression is under negative control of 
GABAergic receptor activation as reported by Metsis et al., 1993.44  
Other possible mechanisms include alteration of coupling of G proteins to 
corresponding receptors, Phospolipase and adenylyl cyclase activity and 
neuronal calcium entry in second messenger system, Effects of decreased 
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cholinergic transmission after ECT, Neurogenesis promotion and apoptosis 
suppression, excitatory amino acid release after ECT.  
 MECHANISM OF COGNITIVE AND AMNESIC EFFECTS OF ECT 
Devanand et al., 1994 45 have shown that ECT does not cause any 
structural brain damage. MRI studies have confirmed such findings in humans 
by Coffey et al., 1991.46 Mechanism of post ECT amnesia is explained by 
excitotoxicity, glutaminergic, cholinergic, hypertensive surge, glucocorticoid, 
and also cyclooxygenase and other related mechanisms.47  
     Hippocampus plays a key role in proper retrieval and memory functioning.48 
It is seen that the hippocampal neurons are more prone to seizures. They 
can be easily excited by little stimuli and are very much sensitive to 
excitotoxicity. Studies on Animal models have shown clearly that ECS which 
is equivalent of ECT in animals caused reduced number of neurons in the 
hippocampus and also in enterorhinal cortex.49 Glial cell activation and also 
high level of neuronal plasticity after ECT is responsible for cell damage in 
neurons. ECT results in brain injury which is very much similar to brain insult. 
Angiogenesis and neurogenesis due to increased neuronal plasticity in later 
stages will be the result, as seen in animal studies conducted by Madsen et al., 
2005.50 After ECT/ECS, there is re-growth and also repair followed by 
activation of glial cells and proliferation triggers the process of neuro-
inflammation. Dwork et al., 2004 51 and Jinno and Kosaka 2008, 52  reported 
that there are many morphological alterations in microglia which are a part of 
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hippocampus. It has also been reported that sprouting of mossy fibres in 
hippocampus in the post-ECT period as a probable mechanism which is 
responsible amnesia produced by ECT. Microglia specifically adapt to the 
neuroinflammatory insult and results in synaptic plasticity and also 
neurogenesis as reported by Ekdahl et al., 200953 and Graeber and Streit 
2010.54 Cholinergic systems in brain have been associated with memory. 
Memory and learning are closely inter-dependent on normal cholinergic 
neuronal transmission. Impairment in these systems has been associated to 
Alzheimer’s disease. Acetylcholine, through Muscaranic receptor, alters the 
conductance of potassium in pyramidal neurons of hippocampus affecting the 
memory.55 
Disruption and blood flow alterations has been suggested as one of 
many mechanisms of the ECT induced amnesia. It is traditionally believed that 
retrograde amnesia induced by ECT arises by disruption of medial temporal 
lobe.  Some authors put forth that disruption of frontal lobe as a cause of this 
mechanism. They demonstrated that loss of autobiographical information due 
to retrograde amnesia in post ECT period is often related with increase in theta 
activity in the fronto-temporal region. There is a good association of sharp 
increase in systolic and seizure in ECT and it is also well documented. This 
increased blood pressure (BP) during seizure causes a “leak” in the blood-brain 
barrier of brain, leading to cerebral edema. This leads to the accumulation of 
proteins and also many macromolecules into the CSF as well as in the 
interstitial spaces of the brain.56  These substances cause disturbances in 
14 
 
neuronal functioning, leading to cognitive impairment. The formation of 
memory is mediated through long‐term potentiation (LTP). It has been very 
well demonstrated earlier that LTP is a glutamate/Ca2+ dependent mechanism. 
It is now accepted widely that LTP is a basic process by which learning and 
memory are mediated   When seizures occurs , it leads to marked increase in 
levels of  intracellular Ca2+ via the mechanism of glutamate‐induced activation 
of NMDA receptors.57 This causes an induction of LTP which results in 
saturation of neuronal system. This saturation results in the ability of further 
induction of LTP to be exhausted completely. Subsequently, the process of 
learning and also recalling is impaired. This theory was supported by the 
studies of McDaniel et al., 2006.58 Home RL  et al., 1984 59 have shown 
independently that the administration of glucocorticoid dexamethasone in 
humans along with ECT resulted in severe amnesia induced by ECT. 
Chamberlin and Tsai, 199860 demonstrated that such amnesic effect could be 
a result of positive feedback of glucocorticoid on NMDA receptors.  
According to studies of Andrade C et al., 2008,61 ECT results in 
cyclooxygenase-2 activity up-regulation that leads to saturation of neuronal 
LTP. These could be the cause for the development of retrograde amnesia. 
Post-seizure changes in neuronal damage have been studied and markers have 
been identified. These markers could help in assessment of previous neuronal 
injury, and help to aid in treatment. In this regard, Brain Derived Neurotrophic 
Factor has been described by Toro et al., 2007,62  Myelin basic protein and 
Glial Fibrillary Acidic Protein  was described earlier  by Gurnett et al.,2003,63  
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neurofilaments as described by Lamers et al., 2003.64  Kato et al., 1982 65 
reported that the neuro specific enolase and S100b protein have been found 
very rarely outside the nervous system and hence they could serve as a reliable 
marker for neuronal change in post ECT period.   
Till date understanding single mechanism of ECT is a great challenge. 
There exists many controversies regarding ECT induced cognitive deficits and 
opposite school of thoughts. 
Sackeim HA et al., 66 in the year 2007 conducted a large study with 260 
patients across various centers in USA. It was a prospective study design. 
Cognitive outcome was analyzed by administering neuropsychological battery 
to all patients. The test batteries were administered before ECT, after 
completing the course of ECT and at follow up of 24 weeks (6 months). The 
batteries include. 
 Modified Mini Mental State Exam scale (MMMSE),Stroop reaction 
time, Choice reaction time and Simple reaction time to assess 
psychomotor function. 
 Continuous performance test (CPT) and Stroop test (ST) to assess the 
attention span. 
 Buschke Selective Reminding Test and Complex figure test (CFT) to 
assess anterograde learning and memory. 
 Autobiographical Memory Interview in short form (AMI-SF) was used 
to assess retrograde amnesia. 
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There was difference in cognitive measures at post ECT which was statistically 
significant. Seven centers showed such differences. AMI-SF and MMMSE 
were the ones which showed considerable differences. They suggested that 
adverse cognitive outcomes were produced by ECT including   deficits in 
global cognitive function and also memory loss which may be present more 
than six months which may be permanent. This was mainly attributed to 
difference in techniques of administering ECT, waveform in which ECT is 
administered and type of placement of electrodes. 
 Effects of ECT in long term on some of memory system had been 
studied in group of patients suffering from bipolar disorder by Glenda 
Macqueen et al., 2007.67 Two groups were one who did not receive ECT and 
another received ECT before six months. Assessment was done for visual 
memory, California test for verbal memory, habit memory and tasks on 
recollection. They found that ECT treated patients had decline in verbal 
learning and had some memory disturbances than controls. This difference was 
not caused by illness itself. They also concluded that these findings may have 
an impact on risk-benefit ratio of this highly effective treatment. This study 
also stressed the importance of addressing the cognitive effects of patients 
treated on ECT and to develop strategies to minimize this side effects.67  
MacKenzie et al 68 assessed cognitive domains in the acute period 
within twenty four hours after administration of ECT. It was given bilaterally 
and the effects were observed. There were sixteen patients who were controls 
and were not administered ECT and thirteen patients who were given ECT. 
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Array of neuropsychological test batteries were administered. They observed 
significant variations on cancellation of letter tasks which measures attention 
component in ECT treated populations. The authors came to a conclusion that 
ECT given bilaterally may result in attention deficits in the acute period.68 
Squire and Slater 69 reported that many patients reported memory 
complaints after ECT subjectively. They compared three groups with patients 
underwent right unilateral ECT, bitemporal ECT and no ECT . Bitemporal 
electrode placement resulted in more reports of memory complaints 
subjectively than other groups immediately after treatment but both groups 
reported significant memory problems than control ECT at seven month follow 
up leading to the suggestion that both bitemporal and right unilateral ECT 
placement lead to subjective memory impairment. These studies are important 
in the fact most of studies in ECT did not demonstrate memory impairment on 
standardized scales though patients had memory problems subjectively.69 
Weeks D et al.,70 studied a group of patients with depression, one group 
received ECT, the other did not receive ECT and one group was normal 
controls. An array of cognitive test batteries was conducted at 4th month and 
also at 7th month after administration of ECT. There was mild deterioration of 
cognitive domains at 4th month and at 7th month there was no significant 
difference from baseline in test batteries. It was also found that illness severity 
has much influence on cognitive domains. In the immediate period, within one 
week of administration of ECT, it was found that ECT given bilaterally had 
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more cognitive decline than ECT given unilaterally. But at the end of three 
months the two groups did not differ on their cognitive domains.70 
Shulze-Rauschenbach et al.,71 showed that anterograde memory 
problems were more for patients underwent right unilateral ECT than with 
repetitive transcranial magnetic stimulation (rTMS) or healthy controls who 
were other groups in the study. Fewer words were remembered from Rey 
Auditory Verbal learning test in groups who had right unilateral ECT than 
other groups. Retrograde amnesia was also seen in ECT patients than rTMS or 
control groups. Variations were found in recalling from verbal and visual 
stimuli given in pre ECT period. Autobiographical memories were not 
impaired while administering Autobiograhical Memory Interview. These 
studies are of view that there is impairment of retrograde memory after 
bitemporal electrode placement. It is less impaired in case of right unilateral 
ECT compared to bitemporal ECT. McElhiney et al., 199772 also concluded 
the same. The study conducted by Schulze-Rauschenbach et al., found that 
there was no significant difference on any non memory cognitive measures 
between different groups in their study. They administered Mini-Mental Status 
Exam (MMSE) for assessment of overall cognitive domain, Trial making test A 
and B for executive functions, Weschler digit span subtest for working 
memory, and Word fluency test for verbal fluency and Letter number span test 
for assessing mental processing speed. Their study revealed the facts that 
memory was the one domain affected while other cognitive domains remain 
unaffected by right unilateral electrode placement compared to rTMS and 
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control population. These studies also suggested that in rTMS population 
memory improved from baseline since depression was treated and illness 
improved but reverse finding were seen in ECT treated populations, memory 
deteriorated from baseline value. Non memory cognitive domains were not 
affected according to this study.     
Bifrontal placement of electrodes was done initially to avoid the 
involvement of hippocampal and temporal regions of brain since they are 
mostly concerned with memory and also in the process of learning in humans 
but the research was not comprehensive due to the fact concerning cognitive 
adverse effects and also the effectiveness of ECT conducted in this type of 
study design by Sackeim et al., 2007.66 
Some authors argued that there will be activation of frontal lobe due to 
bifrontal placement of electrodes which have adverse effects on executive 
functions similar in fashion in which bitemporal placement of electrodes on 
memory by Fattal, Crowley, Dale & Pickle, 2008.73 There is limited number 
of research and evidence on bifrontal ECT and also its various number of 
effects on executive and frontal lobe functions. 
Around 92 patients were subjected to ECT. One group was receiving 
bifrontal ECT and another group was subjected to right unilateral ECT in six 
trials spread over a period of three weeks. There was no significant difference 
in MMSE scores and cognitive domains were equal for both groups and both 
groups were equally effective in treating depression by Eschweiler et al.,74. 
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Bagadia VN et al., 198175 in the year 1981, selected two groups of 
patients. One belonged to schizophrenia categories who were twenty in number 
and another belonged to depressions that were also in same number. They were 
subjected to ECT and were found that there were no post ECT cognitive 
disturbances but some patients complained of memory disturbances 
subjectively.75 
Calev et al., 1995 76 conducted review of many studies from 1975 
regarding non memory cognitive effects of ECT. They came to a conclusion 
that non memory cognitive adverse effects were caused by ECT in many 
patients. Usually cognitive functions are expected to improve after recovering 
from depression but they found that ECT treated patients did not have any 
improvement on cognitive functions taken immediately after ECT 
administration within few days. They also found that within days of ECT 
administration patients were found to be declined on their measures of 
visuospatial and perceptual functions, verbal fluency, intelligence testing and 
executive functions before and after ECT administration. They found that 
cognitive functions other than memory may be impaired by ECT administration 
though cognitive functions may be impaired by illness itself. 
Another important finding of their study is that in their follow up studies after 
ECT administration from one week to seven months they found that nearly all 
measures of cognitive functions came to baseline or improved from baseline 
functioning . It revealed a fact that ECT induced cognitive adverse effects is of 
short span and temporary and improved over time. Further exploration should 
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be made regarding the frontal lobe functioning results and it is indecisive. The 
placement of electrodes in the studies   of Calev et al. mostly had right 
unilateral or bilateral placement of electrodes. The differences in cognitive 
effects by the different electrode placement were not made in their study so it is 
not possible to make any conclusions on non memory cognitive impairments 
due to electrode placement from their study. Furthermore, regardless of 
differences in electrode placement ECT induced impairment in cognitive 
functions are of short duration according to their study.76 
An array of test batteries had been developed for ECT and its related 
cognitive dysfunctions by Vishwanath B et al.,77 from the NIMHANS group 
in 2013 (B4ECT-ReCoDe). He also derived the same conclusion that there is 
no significant difference in pre and post ECT period in cognitive domains. 
A study was done by Avuso-Gutierrez et al., 1982 78  on a number of 
patients suffering from endogenous depression. They compared CPD-choline 
administered patients and patients who were on placebo after receiving bilateral 
ECT and within one day after application of fourth course of ECT. They used 
many of Weschler subscales like time taken for reorientation, Associative 
subtest and digit subtest, memory TEA tests. They did not take into account 
regarding the statistical test. No benefit was seen when CDP-choline was given 
for memory dysfunction induced by ECT.78 
Abrams et al., 1967 79 studied Schizophrenia patients who underwent 
unilateral non-dominant ECT thrice weekly and they were subjected to 
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Weschler memory scale testing. Different tests were applied each for short 
story telling, reproduction of verbal and visual sets, mental control, retention of 
paragraph and digits and orientation within hours of last session of ECT. 
Statistical testing were not done between groups and they also found that there 
was no alteration of cognitive domains between these groups.79 
Another study was done by Pettinati et al., 1984 80 in depression 
patients. Here they compared two populations, one underwent bilateral ECT 
and another group was subjected to unilateral non dominant ECT. Sample size 
was around twenty eight patients. DSM-III was employed for diagnosis. Squire 
memory questionnaire was used to assess memory before and after ECT. 
Unilateral non-dominant ECT caused significant improvement in memory 
scores as opposed to bilateral ECT study design.80 
It has been well established in many studies that ECT affects non 
memory cognitive functions transiently by Calev et al.(1991a),81 
Squire,L.R.(1984),82 Sackeim, H. A. (1992),83 It has also been observed that 
after ECT post-ictal disorientation and soft neurological signs may be seen.84 
Some studies have revealed that verbal fluency may be affected in acute phases 
after ECT by Taylor et al.85 
Shapira et al, 2000 86 studied around forty seven patients who were 
suffering from major depression were selected for the study. ECT was given 
three times per week for one group and two times with sham for another group. 
Cognitive status was assessed at the beginning, after twenty four hours, after 
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three days and at an interval of one month period.  Global test battery was 
employed for the study. They tested for WAIS, tasks on retrograde memory, 
complex figure tests, orientation, tests on immediate memory, visuospatial and 
verbal recall, VPA and test on famous events. There was statistically 
significant reduction in test battery at twenty four hour period and also at three 
days but no difference was noted at a period of one month.86 
Sackeim et al., 2000 87 using Research Diagnostic Criteria, randomized control 
study was designed by employing eighty patients suffering from major 
depression. Effects of ECT given bilaterally with 1.5 times the normal 
threshold were compared with right unilateral ECT which was given in a 
threshold range of 5, 1.5 and 0.5. Results were analyzed at baseline and at a 
period of one week of last ECT. MMMSE, recall of pictures and recall of 
famous events, time taken for reorientation, BSRT, word pairs, faces, complex 
figure test, memory questionnaire by squire (SSMQ), AMI. There was 
improvement seen in all groups with time in SSMQ. All other test groups were 
statistically insignificant. Based on their study, a series of conclusions were 
arrived. Bilateral ECT fared worse followed by High dose right unilateral ECT 
which was followed by medium and low dose right unilateral ECT in 
reorientation to time test. The test was statistically significant. Other tests 
employed such as recall of pictures test by Randt, recall of famous events, 
BSRT, test for AMI, MMMSE, word pairs testing right unilateral ECT was 
better than bilateral ECT. In short story testing by Randt and complex figure 
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test, low and medium dose ECT performed better than high dose right 
unilateral ECT which is very much significant statistically.87 
Lisanby et al., 2000 88 made another comparison made between 
bilateral and right unilateral ECT, high doses of ECT with low doses of ECT 
and another group was normal controls. It was a non randomized study design. 
Nearly fifty five depression patients were taken up for the study. Impersonal 
and personal memory test, personal component of the test (PIMT-) and 
impersonal component of the test (PIM-I) were applied before ECT 
administration and at one week post scores were derived. Control population 
was normal while impersonal component scores deteriorated in ECT group and 
the results were significant statistically. The same result was derived in 
personal component of the test. In all these tests, bilateral ECT patients fared 
poorly with statistically significant results and the dose had no significant 
implications in these tests. Lisanby LH suggested that retrograde and 
anterograde amnesia were produced by ECT.88 
A study was designed by Bailine et al., 2000 89 with depressive patients 
diagnosed as per DSM IV, both unipolar and bipolar depressive patients were 
included. Electrodes were placed in bifrontal region for one group and in 
bitemporal region for another group. MMSE scores were derived after 
application of last ECT. MMSE scores did not alter in bifrontal group but it 
deteriorated with significant statistical values in bitemporal group. Thus they 
came to a conclusion that temporal placement of electrodes resulted in more 
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cognitive impairment than bifrontal electrode placement which has equal 
efficacy but with substantially less impairment than bitemporal placement.89 
Dubovsky et al, 2001 90 employed Refractory depression patients 
diagnosed as per DSM-IV in their study. Sample size was around twenty six 
patients. One group were receiving placebo and another were receiving 
Nicardipine. They used Montogmery-Asberg rating scale for depression, 
Hamilton scale for depression, Beck depression inventory, MMSE and an array 
of test batteries for assessment of neuropsychological functions before 
administration of ECT, after ECT administration and after six months post 
ECT. They derived the results that nicardipine group had depression scores 
which were lower on Montogmery and Hamilton scale while Beck did not 
show any change immediately after ECT completion. At the six month period 
no change was observed between two groups. Cognitive domains deteriorated 
at first and then improved over six month period in both placebo and 
Nicardipine group. No change was observed on MMSE scores. Only significant 
changes were seen in two subtests on battery of neuropsychological tests. No 
difference was found between these two groups on cognitive domains. They 
inferred that adding Nicardipine to ECT may improve anti depressive effects of 
ECT which needs further study but it did not have any effect on cognitive 
effects of ECT.90 
Tang et al 200291 used Piracetam in their study on ECT. A randomized 
study was designed which was double blind and the sample size was thirty 
eight which included both depression and schizophrenia patients. Patients 
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undergoing ECT bilaterally was subjected to placebo in one group and 
Piracetam was put in another group. Effects were analyzed by rating scales and 
also cognitive domains were assessed before ECT, after third and sixth ECT 
and two weeks after the administration of last ECT course. Loading dose of 
piracetam was 7.2 grams and 4.2 grams were used later.  Results were tabulated 
stating that piracetam had no significant effect on ECT related cognitive and 
memory effects. It may have augmented ECT effects in treating illness by 
reducing illness scores compared to placebo group but not significant 
statistically.91 
 McCall et al., 2000 92 in their studies used fixed high dose of right 
unilateral ECT and in another group threshold had been raised to 2.25 times the 
normal. Patient sample size was around seventy two and was suffering from 
depression. MMSE, complex figure test, Rey Auditory Verbal learning test, 
time taken for reorientation test, Duke and rating scales for memory had been 
used for the study. After the study, they found that in some tests like MMSE, 
reorientation time testing and Duke’s test, patients subjected for fixed high 
dose category did not perform well relative to another group and it was 
significant statistically. The results in all other tests were not significant 
statistically.92 
Tew et al., 2002 93 compared high charge ECT given bilaterally with 
ECT given right unilaterally. Patients suffering from depression were taken up 
for the study. Sample size was twenty four. Elderly patients aged fifty and 
above were taken up for study. MMSE scores were analyzed before 
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administration of ECT and after ECT administration within one –three days. 
Patients administered ECT bilaterally had lower scores and performed poorly 
with scores that are significant statistically compared to other group. Around 
eight patients received ECT right unilaterally did poorly but the results were 
insignificant statistically.93    
McCall et al., 200294 gave ECT right unilaterally which was around 
eight times than the threshold stimulus was compared with another group of 
ECT given bilaterally which was 1.5 times than the threshold stimulus. Sample 
size was forty for ECT given right unilaterally and thirty seven for ECT given 
bilaterally. Standardized tests were applied before administration, after 1-3 
days of ECT, two and four weeks after administration of ECT. Both groups 
were similar in their effects to alleviate depression and causing amnesic effects 
which were transient. There was no difference between these groups which 
were significant statistically.94 
Heikman et al., 2002 95 studied around twenty four patients suffering 
from depressive disorder was diagnosed according to DSM-IV. They were 
spread into three groups by comparing the effects of right unilateral ECT about 
400% of the threshold seizure with about 150% of threshold seizure with 
bifrontal ECT which was given just above threshold seizure. MMSE and 
Hamilton scale for depression were used for study. There was much faster 
response with high dose ECT which was given right unilaterally than other 
group. The response rate was much higher with high dose ECT than when 
compared to moderate dose or ECT given bifrontally.95 
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Ranjkesh et al ., 2005 96 compared three groups of study population 
with a sample size of forty five cases diagnosed with depression. They were 
subjected to moderate dose of ECT given bifrontally, high dose of ECT given 
right unilaterally, low dose of ECT given bitemporally. MMSE and Hamilton 
scale for depression were employed for the study. Results revealed that 
Hamilton scale for depression did not reveal any statistical difference between 
these groups. MMSE revealed difference in bifrontal group compared with 
bitemporal and right unilateral population. They concluded their findings that 
all three groups were similar in their effect on treating depression but the group 
in which ECT given bifrontally had much less cognitive adverse effects 
compared with ECT given right unilaterally and bitemporally.96 
Chanpattana et al., 2000 97 took Schizophrenia patients in their study 
to compare the effects of different threshold of ECT given bilaterally. The 
threshold values were 4X, 2X, and 1X. Sample size was sixty two. MMSE and 
NST were applied before and one week after ECT. Cognitive domains did not 
show any significance on statistical values regarding differences between 
groups.97  
Prakash et al., 98 done a study to evaluate the effect of Donepezil on 
cognitive domains in patients who were subjected to ECT. It was a triple blind 
study conducted on 45 patients. They were separated into two groups, one 
receiving donepezil and the other receiving placebo. The patients were 
analyzed before and after administration of ECT. Cognitive domains and 
recovery of patients with respect to cognitive domains were analyzed. Results 
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were tabulated. They found that patients receiving donepezil recovered faster 
than patients receiving placebo on various aspects of cognitive domains in 
post-ECT period. They concluded that this faster recovery time with donepezil 
has therapeutic implications on cognitive deficits in post-ECT period 
immediately.98 
 The major indication of ECT is development of resistance overtime to 
medications. There is also a trend to stop medications before administration of 
ECT. A study was undertaken by Sackeim et al., 2009 99 to compare patients 
receiving placebo and concomitant medications along with ECT (Nortriptline 
or Venlafaxine) and also studied the effects of high dose ECT given right 
unilaterally with moderate dose ECT given bilaterally. Sample size was three 
nineteen, with diagnosis of depression. Hamilton scale for depression rating 
was used. They derived the results that adding Nortriptiline to ECT resulted in 
more efficacious treatment and also resulted in less cognitive side effects than 
the addition of placebo. But Venlafaxine improved the effects of ECT only 
mildly but also resulted in deterioration of cognitive domains. They also found 
that ECT given right unilaterally in high doses resulted in efficacy of treatment 
similar or above than ECT given bilaterally in medium doses with lesser 
adverse effects on cognitive domains compared to ECT given bilaterally.99 
A comparative study was done by Geretsegger et al., 100 between 
methohexital and propofol as anesthetic agents for treating patients with the 
help of ECT. It was a double blind randomized study. They compared the 
quality of seizures, efficacy of response and performance on various aspects of 
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cognition. Patients sample size was around 50 and were diagnosed with 
depressive disorder. One group received propofol and the other received 
methohexital. Duration of seizures, frequency of pulse, and efficacy of seizure 
index, diastolic and systolic blood pressure and also post ictal suppression were 
measured. They were seen before ECT, after 3-5 ECT, after completion of ECT 
course, follow-up at 2 and also 8 weeks. Propofol patients’ quality of seizures 
were shorter, blood pressure was increased mildly in post-ECT period when 
compared to the other group. They concluded their findings that propofol is 
similar in illness improvement but cognitive improvement is better than 
methohexital with only significant results in two trials. So propofol was 
considered a better anesthetic agent for patients receiving ECT.100 
Thirty nine patients older than 60 years were taken up for study by 
Stoppe et al 2006.101 Their diagnosis were depression and they were subjected 
to fixed, high doses of ECT given bilaterally and unilaterally (right unilateral). 
Domains on cognition and severity of illness were tested before ECT 
administration, during and after one month of treatment. Results turned out to 
be same for RUL ECT and bilateral ECT in terms of rates of remission. Illness 
reduction was same in both groups but in terms of cognitive domain ECT given 
bilaterally had poorer outcome compared with other group. Conclusions were 
arrived that both groups were same in reducing the severity of illness but 
bilateral ECT had more cognitive adverse effects compared with RUL ECT.101 
Mohan et al.102 compared two groups undergoing ECT bilaterally, one 
group receiving intensity of stimulus just above threshold of seizure and other 
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receiving 2.5 times above threshold of seizure were compared to assess the rate 
of recovery in manic patients. The effects on cognition were also assessed with 
MMSE. Both groups improved significantly after the treatment course with no 
difference between them. Both type of interventions proved to be safe and 
efficacious with no difference between them statistically.102 
Acute manic patients were assessed by Hiremani et al 103 by giving 
ECT bifrontally and bitemporally with regards to response for treatment and 
cognitive outcomes of the two different electrode placements. Sample size was 
thirty six diagnosed as mania as per DSM-IV criteria. Mood stabilizers were 
not used during the study. YMRS, MMSE, Fluency testing, CFT, learning test 
on paired associate groups and one part of trial making test were employed for 
the study. They concluded that patients who were on treatment with bifrontal 
ECT showed faster recovery when compared to ECT given bitemporally. 
Cognitive domains revealed no difference between the groups significantly.103 
ECT given bifrontally in moderate dose was compared with ECT given 
bitemporally with low dose by Barekatain et al.,104 Sample size was 28 
patients who were diagnosed with manic disorder. MMSE scores and 
standardized rating scale for mania (YMRS) were employed for the study. A 
course of 6 ECTs were given. There was no difference in scores between the 
groups before the administration of ECT. But MMSE scoring of the two groups 
varied significantly after a course of 6 ECTs. ECTs given bifrontally was as 
efficacious as ECT given bitemporally with lesser cognitive adverse effects in 
manic disorder patients.104 
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There was a randomized study by Smith et al 105 in patients suffering 
from unipolar depression to compare two groups to analyze the effects on 
memory between continuation of ECT and continuation of drugs (lithium and 
nortriptyline). Sample size was eighty five and RAVLT, AMI, assessment of 
subjective memory were all employed at twelve weeks and twenty four weeks 
after ECT in addition to baseline assessment. There was statistically significant 
difference on AMI at twelve weeks from baseline in drug group. All others 
were insignificant. There was improvement in memory scoring from twelve to 
twenty four weeks suggesting recovery of deficits in anterograde memory 
induced by ECT. There were no significant changes in outcomes comparing 
both groups.105 
  Effects of cognition in bifrontal and right unilateral with pulses in ultra 
brief duration were compared by Sienaert et al.106 Sixty four depressive 
patients were taken up for study. One group received ECT bifrontally at 1.5 
times the threshold of seizure and another right unilaterally at 6 times the 
threshold. Assessment was made at one week and also at six weeks after ECT 
administration. Cognitive domains were normal in both groups. Memory was 
found to be improved in some patients. Conclusion was arrived that both 
techniques does not have adverse effect on cognition.106 
  Around fifteen patients suffering from depression older than forty five 
years were subjected to bitemporal ECT by Warnell et al.107 One group were 
interrupted in the post seizure period by infusing propofol and another group by 
placebo. One to three days later subscales on WMS were measured like 
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retention of paragraph, orientation, digits, verbal, mental control and short 
story. There was significant delay in auditory and immediate memory. Other 
tests revealed insignificant results. They came to a conclusion that interruption 
of post seizure period by infusing propofol resulted in decreased cognitive 
adverse effects after ECT which may be clinically important.107 
Kellner et al 108 studied bifrontal ECT, ECT given bitemporally and 
right unilaterally in depressive population in a multi centered trial which was a 
double blind and randomized trial.. Two thirty patients were studied. All were 
good in reducing illness severity. ECT given bitemporally had an edge in 
reducing illness severity rapidly than other groups. Cognitive outcomes were 
not significant statistically between groups. They also suggested that bifrontal 
has similar cognitive outcome as that of bitemporal ECT in contrast to other 
studies.108 
Two groups were chosen by Sackeim HA et al.,109  and were given ECT 
bilaterally or right unilaterally at high dosage of stimulus (supra threshold) or 
low dosage of stimulus. Sample size was 71 patients suffering from depression. 
At the end of treatment, after return of orientation, 3 tasks on visual 
cancellations were given immediately following ECT. Omission errors were 
calculated. Intensity of stimulus and type of placement of electrodes were 
noted. They found that ECT given right unilaterally with high intensity resulted 
in neglect of cancellation forms on left side, while asymmetry was noted in 
ECT given in low intensity. On the other hand, ECT given bilaterally in high 
dosage resulted in greater omission in the cancellation forms on right side. 
34 
 
They concluded that when the intensity of stimulus is raised in patients 
receiving ECT unilaterally, the functions of the right hemisphere are more 
affected.109 
A review of studies was done by Verwijk E et al., 110 about ECT given 
right unilaterally in ultra brief pulse and brief pulse wave forms till 2011 were 
undertaken. The effects were analyzed immediately within 1-7 days, 1-6 
months and after six months after administration of ECT. There was 
impairment noted in verbal fluency, memory of personal information and also 
anterograde memory in the immediate aftermath of ECT. There was also 
decline in the processing speed and working memory. There was normalization 
in anterograde memory and verbal fluency at 1-6 months period but 
autobiographical memory was the one which persisted but somewhat improved. 
They concluded that ECT given in ultra brief pulse waveform showed less 
deterioration in autobiographical memory than brief pulse waveforms. All other 
effects on cognitive domains appear to be transient and resolve over time.110 
Cognitive effects in adolescents undergoing ECT were assessed by 
Neera Ghaziuddin et al., 111. They also assessed whether any impairments will 
persist many months following ECT. Sample size was sixteen adolescents 
diagnosed with symptoms of mood disorder. Cognitive domains were assessed 
before, immediately after ECT and months after receiving ECT. They found 
that there was deficits in attention, concentration, delayed recall in verbal and 
visual components and also in component of verbal fluency. There was no 
deficit in the area of ability to solve new problems initially. At months after 
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assessing these deficits were found to be normalized or even improved. They 
concluded that ECT does not cause any long term cognitive deficits and all the 
effects are transient and short lived in immediate period.111 
Cognitive domains were assessed immediately after a single session of 
ECT by Rami et al., 112 A controlled study had been undertaken with a sample 
size of 24 patients who were subjected to ECT as maintenance treatment. They 
were spread as control and experimental group. Effects on visuospatial ability, 
attention processing, frontal and learning functions were made out. Most of the 
cognitive domains remain unaltered after a session of single ECT but there was 
deterioration on visuospatial ability on experimental group after ECT 
implicating that ECT may be responsible for acute effects on cognitive 
domains of right hemisphere.112 
Ng C et al., 113 studied ECT given right unilaterally at 2.5 times the 
seizure threshold with a sample size of 32 patients diagnosed with depression. 
Assessment was made with an array of tests like tests for personal memory 
Wechsler intelligent scale-short version, Randt test for memory, self rating of 
memory were given at the baseline during the treatment course and after one 
month of administration of ECT. There was deficit in anterograde memory in 
the short term period. There was decrease in mean scores in tests for personal 
memory and also in Randt test for memory of 32.5% and 14.8% respectively 
after the course of ECT. All the deficits improved significantly after one 
month. There was no deficit of non-memory cognitive domain. They concluded 
that ECT given right unilaterally does not result in significant or permanent 
36 
 
cognitive impairments, but the effect of treatment is insufficient in clinical 
settings.113 
There is some consensus that ECT results in rise of blood pressure levels 
which may result in the breakdown and breach of blood-brain barrier. A study 
was done by Hamilton et al., 114 with a sample size of 27 patients who were 
diagnosed with depression. Cognitive domains were analyzed with Benton test 
before and 3 hours after administration of ECT. They found that deterioration 
in cognitive domains were correlated significantly when the systolic blood 
pressure raised significantly during the course of treatment.114 
Squire L R reviewed many studies which clarify the nature and the type 
of memory deficits associated with ECT. He also found that ECT given 
bilaterally resulted in significant loss of anterograde memory than ECT given 
right unilaterally. Bilateral ECT also resulted in significant amnesia in 
retrograde fashion than ECT given unilaterally. Memory reactivation just 
before administration of ECT did not result in any type of amnesia. Ability to 
learn things newly were maintained in long term periods after administration of 
ECT but subjective memory complaints is a common feature in patients who 
received ECT bilaterally. Since both treatments are equally efficacious, ECT 
given right unilaterally maybe preferred to ECT given bilaterally, because the 
adverse effects on memory is much lesser. 
Nearly a quarter of patients suffering from dementia also have comorbid 
depression. Nearly one third of them require ECT as a treatment, since they do 
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not recover with anti-depressants. But, the major concern is ECT’s effect on 
cognitive domains and also memory in patients with dementia. 31 patients 
suffering from dementia with depression were administered ECT by Rao V et 
al., 115 MMSE and Montgomery-Asberg scale for depression are employed to 
assess cognitive domains and illness severity respectively. Among the 31 
patients majority had dementia of vascular origin, the next in order was 
degenerative dementia and finally Alzheimer’s dementia. There was a 
statistically significant decline in illness severity which was evident in rating 
scale for depression. Delirium has developed in half of the patients. There was 
also a statistically significant improvement in cognitive domains as evidenced 
by MMSE scores. They concluded that ECT can be used as an effective 
treatment option for patients suffering from dementia with depression which 
leads to global improvements in both cognitive domains and mood. But 
multiple treatments may be an option to achieve this effect.115 
Sackeim et al.,116 selected around 90 patients suffering from depression 
using criteria based on research diagnostics and studied the effects of ECT 
given bilaterally at 2.5 times the threshold of seizure with ECT given right 
unilaterally at 6 times the threshold of seizure either with brief pulse 
waveforms at 1.5ms or ultra brief pulse waveforms at 0.3ms. Effects were 
made out at before administration, immediate period, after one week and also at 
two and six months. Tests conducted include time taken for reorientation, 
recognition of sentence, BSRT, MMSE, test to assess cancellation task, verbal 
fluency, recall of words and recognition, recall of stories,  recognition of 
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shapes, CFT, AMI, recognition of neutral faces. Most of domains declined at 
one week period with statistically significant values. Brief pulse ECT had 
poorer outcomes when compared to ECT given in ultra brief pulse form. 
Performance on cancellation tasks, recognition of words and recall, verbal 
fluency, recognition of faces were declined in brief pulse than ultra brief pulse 
ECT in acute stages with values that were significant statistically. Values on 
CFT, MMSE and also BSRT reveal poor scores on brief pulse when compared 
to ultra brief pulse at one week period. Recall of stories, AMI and rating of 
memory by patients were all declined more with brief pulse than other group at 
one week period. They concluded that ECT given right unilaterally in ultra 
brief pulse had less cognitive decline than other groups. Bilateral ECT had 
more decline on cognitive domains at one week period and also more than ECT 
given right unilaterally.116 
The American agency named Food and drug administration (FDA), 
2011 117 prepared a detailed and exclusive document for assessing the safety 
profile of the ECT machines. The effect of ECT on memory and cognition is 
studied in detail in the summary document by using various literatures. Four 
systematic reviews and meta-analyses were found during their study. 
The following conclusions were obtained from their reviews:  
 Deficits in memory were evident through various literatures. 
 Immediately after the application of ECT or at the end of treatment 
considerable deficits in cognition and memory occurred. 
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 The common type of retrograde memory lost after ECT is 
autobiographical memory 
 Three to four fifth of the patients have such memory loss. 
 Sine wave ECT has a higher impact on memory than brief pulse 
stimulation ECT.   
 The risk of memory impairment after ECT is linked to the placement 
of electrodes on the dominant brain hemisphere and both the 
hemispheres.  
 The energy dose of ECT greatly affects the degree of memory 
deficits. 
 Application of electrical stimulus higher than the  patient’s seizure 
threshold resulted in better results, but increases the risk of memory 
impairment in unilateral ECT. 
 In majority of the patients the memory deficits remaining after 6 
months is not evident from various clinical trials. 
 The effect of ECT on the patients is not altered by the type of mental 
illness they are suffering from.  
 The maximum efficacy of ECT can only be gained by taking a 
greater risk in the deficits of memory.  
 The conclusions are depending on intra-personal and inter-personal.  
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 The quality of life is affected by this type of memory deficits in the 
patients. 
 Comparing the various studies which are performed in this topic has 
a lot of methodology issues.  
According to NICE guidelines118 the time period is divided into the following 
depending on the time duration: 
  Immediate post-ECT effects: this time period includes the first 24 
hours immediately after the termination of ECT seizure during which 
the effects are more acute. 
 Sub-acute post-ECT effects: this time period extends beyond 24 
hours and less than 2 weeks after the final termination of ECT 
seizure during which the ECT effects starts or persists. 
 Medium-term effects: this time period extends beyond 2 weeks and 
less than 3 months after receiving the last ECT course during which 
the ECT effects may start or persist. 
 Longer-term effects: this time period extends beyond 3 months and 
less than 6 months after the final course of ECT during which the 
ECT effects begins or exists. 
 Long term effects: this time period extends 6 months after the last 
course of ECT during which the ECT effects begins or exists. 
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The FDA identified the following using the studies in literature from the Global 
Cognitive Function applying the mini-MMES: 
 The immediate effect of ECT after the treatment is higher when ECT is 
applied bilaterally than when ECT is applied unilaterally is found to be 
proved only by a small amount of evidence. 
 There is no clear evidence in the change of global executive function. 
The existing literatures are also inconclusive and contradictory. 
 Very little evidences are available to prove that placing electrodes 
bitemporally is poorer that placing electrodes bifrontally in the sub-
acute period after applying ECT. These evidences are also found to be 
ambivalent with respect to electrode placement, the energy difference 
and with respect to change from the global cognitive function baseline.  
 It has been found that there are no considerable global cognitive 
function differences between frontal ECT application and unilateral 
ECT and bilateral ECT application of ultra-brief pulse in the medium 
time period.  
 In the “longer-term effects” post-ECT, There are only little evidences 
showing that there is small baseline global cognitive function deviation 
from the baseline assessment in the longer term period.   
 These systematic reviews and meta-analyses also found that placing 
electrodes bilaterally causes a 6 to 10 percentage lesser score of MMSE 
than lacing electrodes unilaterally immediately after the application of 
ECT. There was also no statistical difference in MMSE scores when 
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medium energy and unilaterally placed electrode ECT was compared 
against low energy and unilaterally placed electrode ECT. Similarly no 
differences in MMSE scores were found when the placing electrode 
bilaterally was compared for low energy, medium energy and high 
energy. But, a small difference still existed in these conditions. This 
increased considerably until 2 months after ECT. 
 When patients were administered bilateral ECT and /or high dosage of 
energy in ECT, they had a twelve percent decrease in the score of 
MMSE when compared to the unilateral ECT and/or low dosage of 
energy in ECT. 
.  
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AIMS AND OBJECTIVES 
AIM 
The aim of present study is to assess, evaluate and compare the cognitive 
functions of psychiatric patients prior to and after electroconvulsive therapy 
administration. 
OBJECTIVES 
1. To study the cognitive functions before, immediately after first 
electroconvulsive therapy and at the end of one week of last 
electroconvulsive therapy. 
2. To compare the cognitive functions before and after electroconvulsive 
therapy administration. 
3. To correlate the cognitive functions and illness variable with 
electroconvulsive therapy. 
HYPOTHESIS 
Null hypothesis: 
There is no change in cognitive functions following electroconvulsive therapy. 
Alternate hypothesis: 
There is significant change in cognitive functions following electroconvulsive 
therapy.  
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INCLUSION CRITERIA 
1) Patients suffering psychiatric illness and planned for electroconvulsive 
therapy as recommended treatment option. 
2) Age 18-55 years of both sexes. 
3) Had not subjected to Electroconvulsive therapy within past 6 months. 
4) Had given consent to participate in the study. 
EXCLUSION CRITERIA 
1) Patients with history of co-morbid Axis I psychiatric illness. 
2) Patients having history of physical illness and neurological disorder. 
3) History of previous ECT within six months period.  
4) Patients who are diagnosed as mentally retarded, dementia, substance 
induced and organic psychosis. 
5) History of head injury in the past which is severe enough to cause loss 
of memory and cognitive decline. 
6) Patients having learning disability. 
7) Patients not consented for the study. 
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MATERIALS AND METHODOLOGY 
 
TOOLS USED 
1) Semi-structured Proforma 
2) PGI memory test 
3) Digit symbol substitution test 
4) Color Trial test-1 
5) Color Trial test-2 
6) Controlled Oral Word Association test (COWA) 
7) Addenbrooke’s Cognitive rating scale (ACE-R) 
PGI MEMORY TEST 
The Post Graduate Institute, Chandigarh, memory scale had been 
designed by Pershad and Wig.119 Memory is generally attributed as a temporal 
lobe function. Temporal lobe on right side is responsible for non-verbal 
component of memory and left side to the verbal component of memory. This 
scale provides a simple and very comprehensive technique to assess non verbal 
and verbal memories on the basis of neurological theory. Long term, short term 
and very short term memories are assessed on the basis of evidences 
experimentally and immediate, recent and remote memories on the basis of 
clinical practice setting on evaluation of memory. It is specially designed for 
Indian population. There are ten subtests to assess different components in 
memory such as remote memory, recent memory, mental balance, attention and 
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concentration, delayed recall, immediate recall, verbal retention for similar 
pairs, verbal retention for dissimilar pairs, visual retention and visual 
recognition of some common objects. This test has been well acclaimed and 
validated with international tests like Weschler test for adult intelligence and 
also Boston memory scale. Administration test takes around fifteen minutes. 
DIGIT SYMBOL SUBSTITUTION TEST 
Digit symbol substitution test is a sub test of Weschler Adult 
Intelligence scale.120 It is timed and fine motor test and very much sensitive for 
brain damage, psychiatric and other non neurological problems. It assess the 
mental speed and also sustained attention, visuomotor coordination, response 
speed and motor persistence. Information processing must be rapid to substitute 
symbol for digits quickly and accurately. It contains a sheet of paper in which 
number from 1-9 are arranged randomly in four rows each containing 25 square 
boxes. The subject must do substitution of symbols for digits by using the 
number-symbol key given at the top of sheet. The subject must do the test as 
fast as possible after a practice test and time taken for the test is noted. The test 
usually takes about seven minutes. It is also called digit symbol in WAIS-R, 
Digit-Symbol-Coding in WAIS-III and Coding in WAIS-IV. 
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COLOR TRIAL TEST 
This test was created originally by D’Elia, Satz, Uchiyama and White in 
1996 121 and adopted by WHO as one part of a multicenter study regarding HIV 
infection. It is a derivative of Trial making test and it does not contain 
alphabets and free from language. It consists of two parts. It measures focused 
attention. In addition PART 1 measures simple sequencing, sustained attention 
and perceptual tracking. PART 2 also measures the ability of mental flexibility 
in addition to the above mentioned tasks. It measures focused attention because 
in both parts subjects must ignore the irrelevant numbers and scan for the next 
number in their sequence. In PART 1 of the test, numbers from 1-25 are spread 
randomly in a sheet of paper with pink circles for odd number and yellow 
circles for even number. The subjects must point and connect number from 1-
25 in ascending order. In PART 2 of the test , numbers from 2-25 are printed 
twice once on yellow circles and once on pink circles. In this test subjects are 
asked to point the numbers in ascending order but with alternating colors. It has 
main part and practice test sheet, main parts of color trial are given only after 
the subject has understood the principle and performed satisfactorily in practice 
sheet. Subjects are instructed to do the test as fast as possible and time taken is 
noted down. The test takes about ten minutes. 
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CONTROLLED ORAL WORD ASSOCIATION TEST 
It was previously called as Verbal associative fluency test and now it has 
been changed to COWA test. It is a part of Halstead-Reitan neuropsychological 
test batteries. It measures the verbal fluency and used to assess executive 
functions. Verbal fluency is the capacity of subjects to generate as many new 
words as possible in a manner which is regulated. The new words can be 
generated according to words starting with specific letters or specific category, 
while the former is COWA test and latter is Category test. COWA test was 
designed by Benton and Hamsher in 1989.122 COWA test assess the phonemic 
fluency. In this test subject is asked to name as many new words as possible 
starting with consonants F, A, S. Subjects are instructed not to repeat the same 
words, give the names of person or places. Subjects are also asked to avoid 
proper nouns and giving different suffixes for the same word. If person does 
not know English, they are asked to name with consonants starting from Ka, 
Pa, Ma. A practice test is given with letter other than the indicated letters 
before main test. They are given a three trial with each consonant for one 
minute with a gap in between the trials and the new words generated are noted 
down. The average new words generated in three trials forms the score. This 
test takes about five minutes. 
ADDENBROOKE’S COGNITIVE EXAMINATION-REVISED 
It is a neuropsychological test and it is very brief and used for the 
assessment of overall cognitive functions. It is a theoretically motivated 
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component of MMSE. It is used as a bedside test to assess cognition. It has 
good sensitivity and specificity to identify dementia and also has very good 
patient acceptability. It is very useful to demarcate mild cognitive impairment. 
It is also good to differentiate cognitive decline caused from depression with 
dementia. It also delineates Alzheimer dementia with fronto temporal 
dementia.123 It expands the scope of MMSE which has an overall score of 30. 
ACE-R tests five domains namely orientation and attention, memory, fluency, 
language and visuospatial abilities. A score of 18 for orientation and attention, 
26 for memory component, 14 for fluency, 26 for language component and 16 
for abilities on visuospatial functions is given. The total score for ACE-R test is 
100. The test takes around fifteen minutes. 
OPERATIONAL DESIGN 
This study is a hospital based study which has been conducted at 
Government Medical College Hospital, Tirunelveli. It is a prospective study 
design conducted for a period of one and half years. Approval from 
Institutional Ethical Committee, Government medical college hospital, 
Tirunelveli had been obtained 
The samples selected in the study were patients attending the psychiatry 
department and who were scheduled for Electro convulsive therapy. The 
diagnoses of the condition of patients were performed with ICD-10 criteria.  
After the Institutional Ethical Committee approval had been obtained, patients 
scheduled for Electroconvulsive therapy in the Department of Psychiatry, 
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Government medical college, Tirunelveli were recruited for the current study. 
Informed consent had been obtained. Informed consent in Tamil which had 
been approved earlier by the Institutional Ethical Committee Review Board had 
been used to obtain consent from the participating patients. 
After obtaining consent, patients who meet the exclusion and inclusion 
criteria were enrolled in the study design. Patients taken up for the study were 
able to understand the nature and purpose of the study. Uncooperative patients 
and patients with acute psychosis were ruled out from the study.  
Semi-structured proforma were administered for the patients taken up for the 
study. Socio-demographic profile as per the proforma was collected. Complete 
general physical examination and also detailed neurological evaluation were 
done before the study. All the subjects underwent cognitive assessment which 
lasted around 90 minutes. All the tests were carried out in a fixed order 
according to standardized administration procedure in a quiet room. 
All the patients underwent the tests in the following phases: 
-Baseline: Within 24 hours before administration of ECT. 
-Post 1st ECT: Within 24 hours after administration of 1st session of ECT. 
-Post –ECT: One week after administration of last session of ECT. 
Electroconvulsive therapy is administered using the standard ECT 
machine with a Brief pulse of 60 Hz, 800mAmp and Pulse width of 1.2 ms for 
a total duration of 1 second bifrontotemporally to all the subjects. The 
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treatment process is carried out for all patients are carried out thrice weekly in a 
total of six sittings, unless otherwise specified. General Anesthesia with proper 
and adequate pre-anesthetic medications was given after which patients 
underwent Electroconvulsive therapy. 
The results were collected, tabulated and were analyzed. 
STATISTICAL DESIGN 
The results collected were compared using statistical analysis. Repeated 
measures ANOVA also called as correlated ANOVA is used to compare the 
same subjects who were measured at baseline, after first ECT and one week 
post ECT period. Post- Hoc analysis using Fisher’s test with least significant 
difference was used to compare inter groups and their significance was 
measured after ANOVA testing. To compare the mean difference between two 
different groups (Male and Female) t-test was used. The F values and p values 
which measure the significance of the test have been obtained and tabulated. 
As per statistical design, 95 % confidence interval was set with associated p 
values< 0.05 is significant. Thus the test is significant if p value is less than 
0.05 according to statistical design.  
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RESULTS 
 
Table-1 
Table showing the Socio-Demographic Profile of Patients 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
S.No Variable 
Number of 
Patients 
(n=36) 
Percentage 
(%) 
1 Sex 
Male 23 63.9 
Female 13 36.1 
2 Age 
18 - 25 8 22.2 
26 – 40 25 69.5 
41 - 55 3 8.3 
3 Domicile 
Rural 26 72.2 
Urban 10 27.8 
4 
Socio-
Economic 
Status 
Low 18 50 
Middle 14 38.9 
High 4 11.1 
5 Marital Status 
Married 20 55.6 
Single 16 44.4 
6 Education 
Primary 11 30.6 
Secondary 20 55.6 
Graduate 5 13.8 
7 Diagnosis 
Mania 8 22.2 
Schizophrenia 16 44.5 
Depression 12 33.3 
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Table 1 shows the socio-demographic details of patients who underwent the 
current study. Males in the study were 23 in number which constituted 63.9% 
of study population and females 13 in number which made up 36.1% of 
population. Most common age group of people were 26-40 yrs which made up 
69.5% of population followed by 18-25 yrs and then least people were in 41-55 
yrs age group constituting only 8.3% of population. Most people belonged to 
rural category constituting around 72.2% and urban people made up 27.8% of 
population. Low socioeconomic status was seen in majority of population 
constituting 50% of study, followed by middle and high groups around 38.9% 
and 11.1% respectively. Married population and unmarried people were 20 and 
16 in number respectively. In the current study none of the patients were 
completely illiterate, 11.6% of population at least had primary education and 
55.6% of population had secondary education (>5th STD) and only 13.8% (5 in 
number) were graduated. Schizophrenia patients constituted the majority of 
study population comprising of 44.5% of population (16) followed by 
Depression (12) comprising of 33.3% of population and Mania (8) constituting 
22.2 % of study population. 
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Table-2 
Table showing the Mean, Standard Deviation and Repeated Measures 
ANOVA Scores of Digit Symbol Substitution Test 
 
Table-3 
Table showing Inter-group comparisons using Fisher’s Post-Hoc Test in 
Digit Symbol Substitution Test 
 
 
  
Groups 
(n=36) 
Mean S.D 
Statistics 
F P 
Before ECT 617.39 99.61 
46.64  <0.0001 After 1st ECT 634.33 107.87 
One week post 
last ECT 
577.75 95.08 
S.No Comparison of Groups Statistics 
1 Before ECT and After 1st ECT 
p=0.003 
 
2 After 1st ECT and One week post last ECT 
p<0.0001 
 
3 Before ECT and One week post last ECT 
p<0.0001 
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Graph showing the Mean and Standard Deviation of Digit Symbol 
Substitution Test 
 
The mean scores and standard deviation obtained in Digit symbol substitution 
test were tabulated in Table 2. ANOVA test applied revealed that there was 
significant variation between the baseline, after first ECT and one week post 
completion of ECT. The difference was highly significant statistically. 
(F=46.64)(p<0.0001) 
Table 3 shows the inter group comparison between different phases on Digit 
symbol substitution test. Post Hoc test using Fisher test after ANOVA testing 
revealed that there was significant difference between baseline and first ECT. 
(p=0.003) and the difference between first ECT and 1week post ECT and 
baseline and 1week post ECT were highly significant statistically. (p<0.0001)  
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Table-4 
Table showing the Mean, Standard Deviation and Repeated Measures 
ANOVA Scores of PGI Memory Scale 
 
Table-5 
Table showing Inter-group comparisons using Fisher’s Post-Hoc Test in 
PGI Memory Scale 
  
Groups 
(n=36) 
Mean S.D 
Statistics 
F P 
Before ECT 60.56 7.12 
13.62 <0.0001 After 1st ECT 58.33 7.38 
One week post 
last ECT 
58.22 7.01 
S.No Comparison of Groups Statistics 
1 Before ECT and After 1st ECT p<0.0001 
2 After 1st ECT and One week post last ECT p=0.842 
3 Before ECT and One week post last ECT p<0.0001 
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Graph showing the Mean and Standard Deviation of PGI Memory Scale 
 
The mean scores and standard deviation obtained in PGI memory scale 
were tabulated in Table 4. ANOVA test applied revealed that there was 
significant variation between the baseline, after first ECT and one week post 
completion of ECT. The difference was highly significant statistically. 
(F=13.62)  (p<0.0001) 
Table 5 shows the inter group comparison between different phases on PGI 
memory scale. Post Hoc test using Fisher test after ANOVA testing revealed 
that there was significant difference between baseline and first ECT. 
(p<0.0001) and the difference between first ECT and 1week post ECT was not 
significant statistically (p=0.842) and the difference between baseline and 1 
week post ECT was highly significant (p<0.0001) 
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Table-6 
Table showing the Mean, Standard Deviation and Repeated Measures 
ANOVA Scores of COWA Test  
 
 
 
 
 
Table-7 
Table showing Inter-group comparisons using Fisher’s Post-Hoc Test in 
COWA Test 
 
 
  
Groups 
(n=36) 
Mean S.D 
Statistics 
F P 
Before ECT 6.94 2.40 
16.58 <0.0001 After 1st ECT 6.61 2.10 
One week post 
last ECT 
7.58 2.08 
S.No Comparison of Groups Statistics 
1 Before ECT and After 1st ECT 
p=0.003 
 
2 After 1st ECT and One week post last ECT 
p<0.0001 
 
3 Before ECT and One week post last ECT 
p<0.0001 
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Graph showing the Mean and Standard Deviation of COWA Test 
 
The mean scores and standard deviation obtained in Controlled Oral Word 
Association Test were tabulated in Table 6. ANOVA test applied revealed that 
there was significant variation between the baseline, after first ECT and one 
week post completion of ECT. The difference was highly significant 
statistically. (F=16.58)  (p<0.0001) 
Table 7 shows the inter group comparison between different phases on 
Controlled Oral Word Association test. Post Hoc test using Fisher test after 
ANOVA testing revealed that there was no significant difference between 
baseline and first ECT. (p=0.05) and the difference between first ECT and 
1week post ECT was highly significant statistically (p<0.0001) and the 
difference between baseline and 1 week post ECT was significant (p=0.001).  
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Table-8 
Table showing the Mean, Standard Deviation and Repeated Measures 
ANOVA Scores of Color Trial Test 1 
 
 
 
 
 
 
 
Table-9 
Table showing Inter-group comparisons using Fisher’s Post-Hoc Test in 
Color Trial Test 1 
 
  
Groups 
(n=36) 
Mean S.D 
Statistics 
F P 
Before ECT 195.89 70.56 
42.01  <0.0001 After 1st ECT 210.03 78.01 
One week post 
last ECT 
167.94 67.18 
S.No Comparison of Groups Statistics 
1 Before ECT and After 1st ECT 
p=0.003 
 
2 After 1st ECT and One week post last ECT 
p<0.0001 
 
3 Before ECT and One week post last ECT 
p<0.0001 
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Table-10 
Table showing the Mean, Standard Deviation and Repeated Measures 
ANOVA Scores of Color Trial Test 2 
 
Table-11 
Table showing Inter-group comparisons using Fisher’s Post-Hoc Test in 
Color Trial Test 2 
 
 
  
Groups 
(n=36) 
Mean S.D 
Statistics 
F P 
Before ECT 396.72 105.53 
41.83 <0.0001 After 1st ECT 421.42 117.73 
One week post 
last ECT 
356.19 107.43 
S.No Comparison of Groups Statistics 
1 Before ECT and After 1st ECT p=0.0010 
2 After 1st ECT and One week post last ECT p<0.0001 
3 Before ECT and One week post last ECT p<0.0001 
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Table-12 
Table showing the Mean, Standard Deviation and Repeated Measures 
ANOVA Scores of Color Trial Test Total 
 
 
 
 
 
  
Table-13 
Table showing Inter-group comparisons using Fisher’s Post-Hoc Test in 
Color Trial Test Total 
 
 
 
  
Groups 
(n=36) 
Mean S.D 
Statistics 
F P 
Before ECT 592.61 175.44 
45.68 <0.0001 After 1st ECT 631.44 194.89 
One week post 
last ECT 
524.14 172.67 
S.No Comparison of Groups Statistics 
1 Before ECT and After 1st ECT 
P=0.001 
 
2 After 1st ECT and One week post last ECT 
p<0.0001 
 
3 Before ECT and One week post last ECT 
p<0.0001 
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Graph showing the Mean and Standard Deviation of Color Trial Test 
 
The mean scores and standard deviation obtained in Color Trial Test Total 
score was tabulated in Table 12. ANOVA test applied revealed that there was 
significant variation between the baseline, after first ECT and one week post 
completion of ECT. The difference was highly significant statistically. 
(F=45.68, p<0.0001). 
Table 13 shows the inter group comparison between different phases on Color 
Trial Test Total Score. Post Hoc test using Fisher test after ANOVA testing 
revealed that there was significant difference between baseline and first ECT. 
(p=0.001) and the difference between first ECT and 1week post ECT was 
highly significant statistically (p<0.0001) and the difference between baseline 
and 1 week post ECT was highly significant (p<0.0001). 
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Table-14 
Table showing the Mean, Standard Deviation and Repeated Measures 
ANOVA Scores of ACE-R Test  
 
Table-15 
Table showing Inter-group comparisons using Fisher’s Post-Hoc Test in 
ACE-R Test 
 
  
 Mean S.D 
Statistics 
F P 
Before ECT 70.61 10.74 
82.53 <0.0001 After 1st ECT 69.42 9.83 
One week post 
last ECT 
75.64 9.46 
S.No Comparison of Groups Statistics 
1 Before ECT and After 1st ECT p=0.023 
2 After 1st ECT and One week post last ECT p<0.0001 
3 Before ECT and One week post last ECT p<0.0001 
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Graph showing the Mean and Standard Deviation of ACE-R Test 
 
The mean scores and standard deviation obtained in ACE-R scale were 
tabulated in Table 14. ANOVA test applied revealed that there was significant 
variation between the baseline, after first ECT and one week post completion 
of ECT. The difference was highly significant statistically. (F=82.53, 
p<0.0001) 
Table 15 shows the inter group comparison between different phases on ACE-
R scale. Post Hoc test using Fisher test after ANOVA testing revealed that 
there was mild significant difference between baseline and first ECT. (p=0.023) 
and the difference between first ECT and 1week post ECT was highly 
significant statistically (p<0.0001) and the difference between baseline and 1 
week post ECT was highly significant (p<0.0001). 
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Table-16 
Table showing the Mean, Standard Deviation and Repeated Measures 
ANOVA values in Mania Patients 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
Test 
Mean S.D Statistics 
Before 
E.C.T 
After 
1st 
E.C.T 
One 
week 
post 
last 
E.C.T 
Before 
E.C.T 
After 
1st 
E.C.T 
One 
week 
post 
last 
E.C.T 
F P 
Digit 
Symbol 
Substituti
on Test 
608.12 645.5 555.75 105.28 123.96 99.98 13.49 0.0005 
COWA 
Test 
7.5 7.375 8.25 1.77  2.199  2.1213 5.68 0.0156 
Color 
Trial Test 
1 
178.12  206.5  136.75 71.08  89.14  59.30 12.61 0.0007 
Color 
Trial Test 
2 
377.85 416.5 326.38 106.48 131.64 115.01 14.9 0.0003 
Color 
Trial Test 
Total 
556  623  463.12 177.09 220.39  172.36 15.42 0.0002 
PGI 
Memory 
Scale 
57.625  54  56.75 4.66  4.38  5.52 3.95 0.0436 
ACE-R 
Test 
72.25  68.62  78.12 9.13  7.67 8.30 31.81 <0.0001 
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Table-17 
Table showing the Inter-Group Comparison using Fisher’s Post-Hoc Test 
in Mania Patients 
 
  
Test Comparison of groups Statistics 
Digit Symbol 
Substitution Test 
Before ECT and After 1st ECT 0.045 
After 1st ECT and One week post last ECT 0.004 
Before ECT and One week post last ECT 0.011 
COWA Test 
Before ECT and After 1st ECT 0.685 
After 1st ECT and One week post last ECT 0.021 
Before ECT and One week post last ECT 0.02 
Color Trial Test 1 
Before ECT and After 1st ECT 0.06 
After 1st ECT and One week post last ECT 0.002 
Before ECT and One week post last ECT 0.018 
Color Trial Test 2 
Before ECT and After 1st ECT 0.041 
After 1st ECT and One week post last ECT 0.001 
Before ECT and One week post last ECT 0.021 
Color Trial Test 
Total 
Before ECT and After 1st ECT 0.045 
After 1st ECT and One week post last ECT 0.001 
Before ECT and One week post last ECT 0.016 
PGI Memory Scale 
Before ECT and After 1st ECT 0.014 
After 1st ECT and One week post last ECT 0.106 
Before ECT and One week post last ECT 0.554 
ACE-R Test 
Before ECT and After 1st ECT 0.027 
After 1st ECT and One week post last ECT <0.0001 
Before ECT and One week post last ECT 0.001 
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Table-18 
Table showing the Mean, Standard Deviation and Repeated Measures 
ANOVA values in Schizophrenia Patients 
 
 
  Test 
Mean S.D Statistics 
Before 
E.C.T 
After 
1st 
E.C.T 
One 
week 
post 
last 
E.C.T 
Before 
E.C.T 
After 
1st 
E.C.T 
One 
week 
post 
last 
E.C.T 
F P 
Digit 
Symbol 
Substituti
on Test 
661.12  667.68 621.62 93.73 100.79  88.54 24.26 <0.0001 
COWA 
Test 
6.18  5.88 6.68 5.76 2.65  2.095 3.67 0.0375 
Color 
Trial Test 
1 
233.56 241.62  212.12 64.28  69.86 60.22 18.41 <0.0001 
Color 
Trial Test 
2 
447.06  460.31 410.94 95.48  103.18 93.395 16.16 <0.0001 
Color 
Trial Test 
Total 
680.62 701.94  623.06 158.96 172.14  
 
151.89 
 
18.11 <0.0001 
PGI 
Memory 
Scale 
55.93 54.06 53.25 4.040 4.007  3.87 7.82 0.0018 
ACE-R 
Test 
64.13 63.68 
 
69.56 
 
10.07  8.60 8.66 42.66 <0.0001 
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Table-19 
Table showing the Inter-Group Comparison using Fisher’s Post-Hoc Test 
in Schizophrenia Patients 
 
 
  
Test Comparison of groups Statistics 
Digit Symbol 
Substitution Test 
Before ECT and After 1st ECT 0.313 
After 1st ECT and One week post last ECT <0.0001 
Before ECT and One week post last ECT <0.0001 
COWA Test 
Before ECT and After 1st ECT 0.289 
After 1st ECT and One week post last ECT 0.007 
Before ECT and One week post last ECT 0.178 
Color Trial Test 1 
Before ECT and After 1st ECT 0.159 
After 1st ECT and One week post last ECT <0.0001 
Before ECT and One week post last ECT <0.0001 
Color Trial Test 2 
Before ECT and After 1st ECT 0.155 
After 1st ECT and One week post last ECT 0.0002 
Before ECT and One week post last ECT 0.0002 
Color Trial Test Total 
Before ECT and After 1st ECT 0.154 
After 1st ECT and One week post last ECT <0.0001 
Before ECT and One week post last ECT <0.0001 
PGI Memory Scale 
Before ECT and After 1st ECT 0.007 
After 1st ECT and One week post last ECT 0.277 
Before ECT and One week post last ECT 0.003 
ACE-R Test 
Before ECT and After 1st ECT 0.535 
After 1st ECT and One week post last ECT <0.0001 
Before ECT and One week post last ECT <0.0001 
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Table-20 
Table showing the Mean, Standard Deviation and Repeated Measures 
ANOVA values in Depression Patients 
Test 
Mean S.D Statistics 
Before 
E.C.T 
After 
1st 
E.C.T 
One 
week 
post 
last 
E.C.T 
Before 
E.C.T 
After 
1st 
E.C.T 
One 
week 
post 
last 
E.C.T 
F P 
Digit 
Symbol 
Substitu
tion Test 
565.25 582.42 533.92 82.00 93.48 80.38 15.61 <.0001 
COWA 
Test 
7.58 7.08 8.33 2.64 2.43 2.42 10.63 0.00059 
Color 
Trial 
Test 1 
157.50 170.25 129.83 55.56 66.81 45.25 18.24 <.0001 
Color 
Trial 
Test 2 
342.17 372.83 303.08 92.71 117.31 91.27 12.56 0.00023 
Color 
Trial 
Test 
Total 
499.67 543.08 432.92 147.82 183.68 135.93 15.03 <.0001 
PGI 
Memory 
Scale 
68.67 66.92 65.83 4.05 4.32 4.00 8.95 0.00143 
ACE-R 
Test 
78.17 77.58 82.08 7.07 6.92 5.95 25.39 <.0001 
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Table-21 
Table showing the Inter-Group Comparison using Fisher’s Post-Hoc Test 
in Depression Patients 
 
 
  
Test Comparison of groups Statistics 
Digit Symbol 
Substitution Test 
Before ECT and After 1st ECT 0.047 
After 1st ECT and One week post last ECT 0.001 
Before ECT and One week post last ECT 0.002 
COWA Test 
Before ECT and After 1st ECT 0.082 
After 1st ECT and One week post last ECT 0.003 
Before ECT and One week post last ECT 0.005 
Color Trial Test 1 
Before ECT and After 1st ECT 0.043 
After 1st ECT and One week post last ECT 0.0005 
Before ECT and One week post last ECT 0.001 
Color Trial Test 2 
Before ECT and After 1st ECT 0.041 
After 1st ECT and One week post last ECT 0.0006 
Before ECT and One week post last ECT 0.015 
Color Trial Test 
Total 
Before ECT and After 1st ECT 0.041 
After 1st ECT and One week post last ECT 0.0004 
Before ECT and One week post last ECT 0.005 
PGI Memory Scale 
Before ECT and After 1st ECT 0.029 
After 1st ECT and One week post last ECT 0.121 
Before ECT and One week post last ECT 0.002 
ACE-R Test 
Before ECT and After 1st ECT 0.349 
After 1st ECT and One week post last ECT <0.0001 
Before ECT and One week post last ECT 0.001 
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Table-22 
Table showing the Mean difference between before ECT and 1 week 
post ECT and corresponding  Standard Deviation ,t-Test values in 
Male and Female Patients 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Test 
Male Female 
P value 
Mean 
difference 
S.D 
Mean 
difference 
S.D 
Digit 
Symbol 
Substitution 
Test 
40.39 29.09 38.3 35.1 0.849 
COWA 
Test 
-0.39 1.15 -1.07 0.75 0.065 
Color Trial 
Test Total 
74.52 58.7 57.76 67.53 0.441 
PGI 
Memory 
Scale 
2.21 2.96 2.53 3.4 0.769 
ACE-R 
Test 
-5.26 2.83 -4.61 4.01 0.576 
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Graphs showing the Mean and Standard Deviation Comparison of 
Mania, Schizophrenia and Depression Patients in Various Tests 
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DISCUSSION 
The present study attempted to identify the short-term effect of bilateral, 
brief pulse ECT on cognitive functions among patients who were listed for 
such treatment in this center. Uniform application of ECT using the same 
calibrated machine and the same protocols (pulse-width, frequency, time and 
peak current, bi temporal application of ECT and similar general anesthesia 
with muscle relaxants) ensured that the delivery of the current was same to all 
patients. In the present study, the study population was nearly homogenous and 
the same patient, subsequent data were used to compare the effect of the ECT.   
In Digit symbol substitution test which is a sub test of Weschler 
Intelligence Scale mainly assess the mental speed, sustained attention, 
visuomotor coordination and motor persistence. In our study population there is 
a decreasing trend seen immediately after application of first ECT from 
baseline. Time taken to complete the task increased from baseline score (M-
617.39-634.33) which was significant (p=0.003). This suggests that ECT has 
acute effects on attention, mental speed, visuomotor and information 
processing in the immediate period within 24 hrs of application of ECT. But 
one week after completion of ECT course revealed that the time taken to 
complete the task decreased from baseline with a mean score of (M-577.75) 
and the difference was very much significant (p<0.0001) with most of study 
population performing better when compared to baseline. Thus in our study 
group it revealed that after completion of ECT course attention, mental speed 
and information processing were improved and it is revealed by Digit Symbol 
76 
 
substitution test. These attention deficits noted in the acute phase after ECT is 
consistent with reports of earlier studies.68, 76, 112 
The amnesic effect of ECT treatment still has not been deciphered 
completely till date.55Many theories have been proposed and several methods 
have been attempted to reduce these amnesic effects of ECT treatment.61Unless 
the effects of the various domains and characters of this amnesic defects are 
studied, the mechanism by which ECT causes amnesia could not be completely 
deciphered. Hence several tools dealing with various domains of memory have 
been traditionally used by several authors.66, 69, 71, 76 
In assessing the PGI memory scale scores it was observed that 
immediately after application of first ECT there was a reduction of mean scores 
from baseline (M-60.56-58.33). This decline on memory function was 
significant (p<0.0001). On examining the mean score at one week post last 
ECT it further deteriorated. (M-58.22). This decrease in memory function was 
not significant when compared to first ECT (p< 0.842) but the decline was very 
much significant when compared to baseline(p<0.0001). Thus it can be clearly 
seen that ECT has an adverse cognitive outcome with regards to memory which 
can be evident even after application of first ECT. Thus it can be observed that 
with passage of time there is decline in memory and it did not attain baseline or 
improve after a course of ECT. These findings are consistent with earlier 
studies and reports.66,67,69,117  Our study did not take into account the long term 
impact of ECT on memory in which various studies have different views.ECT 
affects both retrograde and anterograde memory and in retrograde memory 
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specifically autobiographical memory is found o be affected in long term.117 
There are studies which have investigated effects of ECT on several intellectual 
tasks after recovery of orientation after ECT.23, 25 In such studies authors have 
used memorized word lists, geometric shapes, nonsense shapes, and neutral and 
emotional faces before the treatment. After ECT exposure the patients were 
tested again on recall and recognition immediately after recovery of 
orientation. Demonstration of memory deficits at this time may in future 
develop a more long-lasting amnesia. This could be due to secondary to a 
common and general post-ictal delirium, which is reported in longer term 
cognitive impairment.  
In Controlled Oral Word Association test which is a part of Halstead-
Reitan neuropsychological test battery assess the verbal fluency which is a part 
of executive function there is decline from baseline to first ECT (M-6.94-6.61) 
in our study group but the decline was insignificant statistically (p=0.05). This 
effect of ECT on verbal fluency and executive functions has been reported in 
earlier studies.73,85 There was significant improvement after completion of 
course of ECT in the one week period with mean scores improving more than 
baseline scores (M-6.94-7.58) which is significant statistically (p=0.001). Thus 
effects seen after first ECT were not seen after completion of course of ECT 
and resulted in improvement in verbal fluency test.76  
In Color trial test total mean scores, the time taken to complete the test 
increased from baseline mean scores (M-592.61- 631.44) which suggests that 
the patients have declined in their performance on focused attention, perceptual 
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tracking, simple sequencing and mental flexibility which are measured by these 
tests after application of first ECT in the immediate period (within 24 hrs of 
application of ECT). But there is significant improvement in due course which 
is evident in the post ECT period in which patients completed the task earlier as 
compared to baseline (M-524.14) which is significant as compared to baseline 
(p<0.0001). Similar findings have been observed in part 1 and part 2 of color 
trial test. Thus ECT has acute effects on attention in the immediate aftermath of 
ECT application.81 ECT also has effects on visuospatial abilities and 
hemispheric neglect in the acute stages noted immediately after ECT 
application as seen in earlier studies.109 
In ACE-R scale scores which measures the overall cognitive 
performance, it was observed that in the immediate period after application of 
first ECT, there was decline in cognitive performance in our study population 
from baseline scores (M-70.61-69.42) but the decline was mildly significant 
statistically (p=0.023). Thus ECT has acute effects on cognitive functions in 
the immediate period as reported in earlier studies.86 But after completion of 
ECT course in the one week post ECT period it was observed that scores 
improved from baseline (M-75.64) which was highly significant statistically 
(p<0.0001). Thus as passage of time, ECT resulted in improvement in cognitive 
scores which has been described in several studies. In select individuals, with 
general anesthesia, post-ictal delirium and or confusion, the MMSE scores have 
been reported to decrease owing to organic changes. But such a change needs 
to be at least 25% less of the baseline MMSE scores to be classified as an 
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organic damage related one. In the present study, none of the patients exhibited 
a rapid decrease of 25% of the ACE-R scores (which assess the overall 
cognitive performance like MMSE with extensive scoring) from baseline 
parameters. This indicates that none of the patients in this study population 
experienced an organic damage. This findings have been reported earlier by 
Calev et al.,76 The transient effects produced by ECT in the acute stages 
immediately as reported in studies81-83,114 was found to be resolved  in later 
stages and it ultimately resulted in cognitive improvement by decreasing illness 
severity . Thus the detrimental effect of ECT is short lasting and after the 
course of ECT cognitive domain improves over time. These results are very 
much consistent with earlier studies.70,76,110,111,115 
On comparing the illness variable it was observed that in digit symbol 
substitution test schizophrenia patients had taken more time to complete the 
task (M-661.12) followed by mania patients (M-608.12) and depression group 
(565.25). In the immediate period post first ECT there was significant decline 
in scores in mania and depression patients (p=0.045 and 0.047) but the decline 
in scores of schizophrenia patients was insignificant statistically (p=0.313). But 
after completion of ECT course all three groups have improved scores than 
baseline which was statistically significant from baseline scores (p=0.011, 
p<0.0001, p=0.002) for mania, schizophrenia and depression group 
respectively. Thus ECT has resulted in improvement in this task on all three 
groups. 
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In PGI memory scale scores, there was significant memory impairment 
after first ECT in all three groups (p=0.014, p=0.007 and p=0.029) for mania, 
schizophrenia and depression patients respectively but post one week after 
completion of ECT mania patients had insignificant memory impairment 
compared to baseline . Their memory scores neared baseline values (p=0.554) 
but significant memory impairment persisted in schizophrenia (p=0.003) and 
depression groups (p=0.002) but the changes from first ECT to one week post 
ECT were insignificant in all three groups. Thus in mania patients memory 
neared baseline values but other two groups had significant memory 
impairment post ECT. 
In COWA test ECT resulted in insignificant impairment in verbal 
fluency in all the three groups with insignificant p values in the immediate 
period after first application of ECT. After completion of course of ECT it was 
observed that there was improvement in verbal fluency which was significant 
in mania and depression groups (p=0.02 and p=0.005) and insignificant in 
schizophrenia population (p=0.178) from baseline values. Thus improvement in 
verbal fluency is seen in mania and depression populations but improvement 
seen in schizophrenia was insignificant after completion of course of ECT. 
In color trial test total score there was significant decline in performance 
in mania and depression groups revealed by increased time to finish the task 
after first ECT (p=0.045 and p=0.041) respectively. Decline seen in 
schizophrenia group was insignificant (p=0.154) but after completion of course 
of ECT time taken to finish the task decreased significantly in all the three 
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populations from baseline and their baseline scores improved ( Focused 
attention, perceptual tracking and mental flexibility) all improved from baseline 
and also improved when comparing to first ECT. 
In ACE-R scale after measuring immediately post first ECT, significant 
decline in cognitive scores is seen in mania patients (p=0.027) but the decline 
seen in schizophrenia and depression groups were insignificant (p=0.535 and 
p=0.349) respectively. Thus cognitive scores declined in manic populations 
significantly after application of first ECT. But overall cognitive outcome 
improved significantly in one week post ECT period compared with first ECT 
and it even fared better than baseline and there was significant cognitive 
improvement in all three groups compared to baseline. Thus ECT improves the 
cognitive outcomes in all three groups. ECT related cognitive effects were 
independent of type of mental illness.117   To compare the effects of ECT 
related cognitive outcomes in male and female populations, mean difference in 
scores of baseline and one week post ECT were taken into account and the 
mean difference in male and female populations were compared using t-test . It 
was noted that in digit symbol test the mean difference in male population was 
40.39 and female population was 38.3 and the difference between groups were 
insignificant (p=0.849). Similarly in PGI memory scale the mean difference in 
male and female population were 2.21 and 2.53 respectively and the two 
groups did not differ statistically (p=0.769). Similarly the mean difference in 
COWA test were -0.39 and -1.07 in males and females and revealed 
insignificant results (p=0.065). 
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 In color trial test, the male and female population had a score of 74.52 
and 57.76 respectively and the groups did not differ significantly in this test 
(p=0.441) and in ACE-R scale the mean difference between baseline and one 
week post last ECT in males was -5.26 and females was -4.61 and they did not 
differ in their outcomes (p=0.576) .Thus it is observed that ECT  related 
cognitive outcomes did not differ according to gender and both male and 
female populations had similar cognitive outcomes which is seen by measuring 
the mean difference between baseline and post ECT period in both groups. It 
did not vary according to gender and same results were seen in different tests.  
Since literature evidences favoring ECT by itself causing cognitive 
improvement are few, any improvement in cognitive outcomes can be 
attributed to ECT causing illness improvement and recovery thereby indirectly 
improving cognitive functions. 
Advantages of this study are the scales and tests used were administered by the 
single person therefore interrator bias has been eliminated. ECT has been given 
to all subjects with same calibrated machine following same protocol thereby 
eliminating any procedural bias. Three different disorders were compared and 
cognitive evaluation was made before and after ECT.   
The limitation of this study is that it has used only a small sample size with 
minimal varying factors. The educational and occupational skills have not been 
taken as potential factors that could cloud the results. In addition, the duration 
of the disease, stage of the diseases, other co-morbidity (if any) had not been 
83 
 
looked into. The qualitative complaint of the patients or caregiver’s feedback 
has not been accounted. The effect of diminishing memory on quality of life 
could have been studied, which would shed light in to the deviation from 
normal life.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
84 
 
CONCLUSION 
The current prospective study has evaluated the cognitive outcomes of 
electroconvulsive therapy. It can be concluded from this study that 
 ECT treatment has effects on memory as well as other non memory 
cognitive functions. 
 ECT has acute effects on cognitive functions which are clearly evident 
by changes in cognitive profile of participating patients seen 
immediately after first ECT. 
 The cognitive effects caused by ECT is short-lived and reversible which 
is evident by changes in cognitive outcomes from first ECT to one week 
post ECT period 
 ECT ultimately resulted in improved cognitive outcomes on all domains 
except memory which is evident at one week post ECT period in which 
all domains showed improved or attained baseline values except 
memory.  
 Furthermore long term effects of ECT on memory has not been taken 
into account which may have different outcomes on memory 
 Gender difference did not play a significant role on ECT related 
cognitive outcomes. 
 Schizophrenia has the most and depression has the least illness related 
cognitive impairment which is evident by baseline cognitive values of 
these three disorders.  
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 ECT resulted in improved cognitive outcomes of all these three 
disorders except memory. This cognitive improvement seen in these 
disorders can be attributed to decrease in illness severity by 
administration of ECT thereby improving cognitive outcomes. 
Further studies should include larger sample size with wider tools and having a 
longer feedback along with biological markers of the brain changes. Such a 
study would help to decipher the changes that ECT brings on cognitive 
functions and thereby the quality of the life of these patients.  
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ANNEXURES 
 
 
 
 
 

 MASTER CHART 
S.No Name Sex/Age Dom Edu Marital SES Dia
DSST COWA CTT 1 CTT 2 CTT T PGI ACE-R 
I II III I II III I II III I II III I II III I II III I II III 
1 RAMESH M/28 U Sec Sin Low S 784 803 716 3 4 4 321 342 283 594 645 524 915 987 807 51 54 53 54 56 62 
2 MUTHU KUMAR M/25 R Sec Sin Mid S 554 578 523 8 6 8 171 184 157 365 398 332 536 582 489 60 57 56 77 74 80 
3 LAKSHMANAN M/54 R Pri Mar Low D 726 759 683 4 4 6 249 282 204 485 542 447 734 824 651 62 59 61 66 67 75 
4 SUBRAMANIAN M/30 R Gra Mar Low S 614 588 574 7 7 7 205 187 179 401 375 351 606 562 530 57 59 52 66 68 73 
5 JEBA RATHNAM F/33 U Sec Mar Mid M 513 498 442 8 9 9 117 93 79 287 242 196 404 335 275 63 57 65 82 80 89 
6 PARAMESHWARI F/30 R Gra Mar Low S 766 785 715 4 5 6 301 328 287 550 587 506 851 915 793 52 52 52 55 58 63 
7 PERUMAL M/40 R Sec Mar Low S 597 611 546 9 7 8 185 199 165 396 418 353 581 617 518 58 56 56 71 70 77 
8 SANTHANA KUMAR M/22 R Sec Sin Low D 612 651 577 7 8 8 197 211 158 431 474 376 628 685 534 67 69 67 76 75 80 
9 MUTHU KUMAR P M/23 U Sec Sin High M 521 597 487 6 6 8 129 153 83 302 365 223 431 518 306 55 50 57 69 67 76 
10 KANAGALAKSHMI F/28 U Pri Sin Mid S 685 705 617 5 5 7 252 283 230 463 503 429 715 786 659 55 52 47 61 59 63 
11 NALLA THAI F/38 R Pri Mar Low D 484 469 451 12 10 13 94 84 79 251 233 185 345 317 264 73 68 70 88 84 89 
12 RAJAN M/35 R Sec Sin Mid S 707 693 673 4 6 6 275 261 254 476 455 433 751 716 687 54 49 49 58 55 63 
13 MOBIN M/24 R Sec Sin Low M 684 721 604 6 5 6 238 258 156 463 511 385 701 769 541 53 51 52 64 63 70 
14 VANITHA F/31 U Gra Mar Mid S 746 787 692 4 4 6 290 327 255 495 547 438 785 874 693 52 51 50 54 53 58 
15 ARUNA F/28 R Sec Mar Low M 632 674 583 9 8 10 195 239 138 417 449 392 612 688 530 60 61 59 76 66 82 
16 SHANMUGA AYYA M/54 R Pri Mar High D 668 698 633 6 6 6 226 252 184 446 520 380 672 772 564 63 62 61 70 68 73 
17 KANI RAJ M/55 R Sec Mar Low D 532 533 504 5 5 7 138 126 102 331 296 238 469 422 340 66 64 65 73 74 81 
18 MUTHU KUMARAN M/28 R Pri Sin Mid S 651 626 628 6 5 5 238 217 226 467 441 416 705 658 642 56 53 53 64 64 68 
19 MANIMALA F/30 U Sec Mar Low D 552 519 496 7 6 8 163 148 119 360 328 312 523 476 431 71 72 69 81 84 87 
20 MAAN RAJ M/23 R Sec Sin Mid S 805 783 759 5 5 7 336 325 287 613 584 573 949 909 860 50 49 52 50 55 62 
21 ARUMUGASUNDARI F/37 R Pri Mar Low M 553 655 512 10 11 11 141 209 109 348 423 304 489 632 413 57 51 58 73 68 82 
22 MALLIGA F/20 R Sec Sin Low S 593 620 613 8 7 8 193 217 204 415 447 432 608 664 636 59 55 50 73 67 69 
23 JOHN M/23 R Sec Sin Mid S 538 507 487 10 8 9 157 133 121 341 301 298 498 434 419 61 56 58 78 75 82 
24 SIMSON M/29 R Gra Mar Mid D 593 629 534 6 5 6 174 204 136 374 441 329 548 645 465 68 65 66 78 78 85 
25 ALEX PANDIYAN M/26 R Sec Sin Low M 696 737 719 7 6 7 184 262 218 392 480 447 576 742 665 56 50 47 67 62 69 
26 RAMALAKSHMI F/30 U Sec Mar High S 739 778 679 4 4 6 277 298 255 492 537 445 769 835 700 53 52 52 55 55 64 
27 VELLA THAI F/40 R Pri Mar Low D 628 658 601 9 10 9 218 245 178 435 494 393 653 739 571 66 63 59 75 71 76 
28 MUTHU KUMAR S M/27 R Sec Mar Mid M 487 456 448 9 9 10 106 91 85 243 239 187 349 330 272 65 59 61 87 81 88 
29 CHANDRA BABU M/34 R Sec Mar Low D 508 489 485 8 7 9 104 90 81 236 205 185 340 295 266 72 71 69 85 85 87 
30 PALANI KUMAR M/26 U Gra Sin Mid S 487 504 456 11 10 9 104 132 88 231 274 196 335 406 284 65 65 63 84 82 88 
31 GOMATHI F/30 R Pri Sin Mid D 514 544 563 7 6 7 119 143 151 257 322 358 376 465 509 69 71 67 75 76 77 
32 KARUPPASAMY M/27 R Pri Mar Low S 678 703 691 6 6 5 225 246 232 430 466 484 655 712 716 55 53 53 60 61 66 
33 SUBASH RAJ M/26 U Sec Sin High M 779 826 651 5 5 5 315 347 226 571 623 477 886 970 703 52 53 55 60 62 69 
34 NAAMA SELVAM M/37 U Pri Mar Low D 442 491 404 13 12 13 83 106 72 222 258 196 305 364 268 75 72 72 89 88 91 
35 SAMUTHIRAVALLI F/28 R Pri Mar Mid S 634 612 577 5 5 6 207 187 171 424 387 365 631 574 536 57 52 56 66 67 75 
36 MICHAEL RAJA M/23 R Sec Sin Mid D 524 549 476 7 6 8 125 152 94 278 361 238 403 513 332 72 67 64 82 81 84 










 
 
  
  
  
 


